D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 47 Citations 9,632 115 World Ranking 14567 National Ranking 6101

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Enzyme
  • DNA

Michael S. Glickman mainly investigates Mycobacterium tuberculosis, Microbiology, Genetics, Immunology and Tuberculosis. The Mycobacterium tuberculosis study combines topics in areas such as Virulence, Ribosomal RNA, Transcription factor, RRNA transcription and Effector. His work deals with themes such as Cord factor, Trehalose dimycolate, Stringent response, Mycolic acid and Innate immune system, which intersect with Microbiology.

His Immunology research focuses on subjects like Infectious disease, which are linked to Leprosy, Mycobacterium bovis and relapsing fever. His study looks at the intersection of Tuberculosis and topics like Gene with PCAA. His work carried out in the field of DNA ligase brings together such families of science as Homology directed repair, Circular bacterial chromosome and Cell biology.

His most cited work include:

  • A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. (529 citations)
  • The mechanism of action of BCG therapy for bladder cancer—a current perspective (306 citations)
  • Microbial Pathogenesis of Mycobacterium tuberculosis: Dawn of a Discipline (257 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Mycobacterium tuberculosis, Tuberculosis, Biochemistry, Microbiology and Cell biology. His Mycobacterium tuberculosis research includes themes of Genetics, Virology, Immunology, Cell envelope and Virulence. His study focuses on the intersection of Tuberculosis and fields such as Antibiotics with connections in the field of Isoniazid.

His Biochemistry study integrates concerns from other disciplines, such as Mycobacterium smegmatis and Mycolic acid. His Microbiology study combines topics in areas such as Transcription factor, Cord factor and Trehalose dimycolate. His work in the fields of Cell biology, such as Mediator and Effector, intersects with other areas such as Structure and function.

He most often published in these fields:

  • Mycobacterium tuberculosis (58.00%)
  • Tuberculosis (40.67%)
  • Biochemistry (39.33%)

What were the highlights of his more recent work (between 2017-2021)?

  • Tuberculosis (40.67%)
  • Mycobacterium tuberculosis (58.00%)
  • Cell biology (36.00%)

In recent papers he was focusing on the following fields of study:

Tuberculosis, Mycobacterium tuberculosis, Cell biology, Cytoplasm and Microbiology are his primary areas of study. He works mostly in the field of Tuberculosis, limiting it down to topics relating to Immune system and, in certain cases, Infectious disease and Bladder cancer. As part of his studies on Mycobacterium tuberculosis, he often connects relevant subjects like Immunology.

His work on Effector and Phosphorylation as part of general Cell biology research is frequently linked to Repressor lexA and Cardiolipin, thereby connecting diverse disciplines of science. His Cytoplasm research includes elements of Cell wall and Mycolic acid. In his study, Transcription, Bacterial genetics and Rifamycin is inextricably linked to Polymerase, which falls within the broad field of Microbiology.

Between 2017 and 2021, his most popular works were:

  • TOX is a critical regulator of tumour-specific T cell differentiation (231 citations)
  • TOX is a critical regulator of tumour-specific T cell differentiation (231 citations)
  • Determinants of COVID-19 disease severity in patients with cancer. (167 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • DNA
  • Enzyme

The scientist’s investigation covers issues in Biochemistry, Cancer, Cell, Cancer research and T cell. Many of his research projects under Biochemistry are closely connected to Chemical synthesis and Adduct with Chemical synthesis and Adduct, tying the diverse disciplines of science together. He combines subjects such as Mortality rate, Mechanical ventilation and Chemotherapy with his study of Cancer.

His research in Cancer research intersects with topics in T cell differentiation, T-cell receptor, TIGIT, Memory T cell and Effector. In his study, Mycobacterium tuberculosis is strongly linked to Innate immune system, which falls under the umbrella field of T cell. Michael S. Glickman studies Latent tuberculosis which is a part of Mycobacterium tuberculosis.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis.

Michael S Glickman;Jeffery S Cox;William R Jacobs.
Molecular Cell (2000)

782 Citations

The mechanism of action of BCG therapy for bladder cancer—a current perspective

Gil Redelman-Sidi;Michael S. Glickman;Bernard H. Bochner.
Nature Reviews Urology (2014)

560 Citations

Determinants of COVID-19 disease severity in patients with cancer.

Elizabeth V. Robilotti;Elizabeth V. Robilotti;N. Esther Babady;Peter A. Mead;Peter A. Mead;Thierry Rolling.
Nature Medicine (2020)

515 Citations

Microbial Pathogenesis of Mycobacterium tuberculosis: Dawn of a Discipline

Michael S. Glickman;William R. Jacobs.
Cell (2001)

509 Citations

TOX is a critical regulator of tumour-specific T cell differentiation

Andrew C Scott;Andrew C Scott;Friederike Dündar;Paul Zumbo;Smita S Chandran.
Nature (2019)

482 Citations

Mycobacterium tuberculosis nuoG Is a Virulence Gene That Inhibits Apoptosis of Infected Host Cells

Kamalakannan Velmurugan;Bing Chen;Jessica L Miller;Sharon Azogue.
PLOS Pathogens (2007)

366 Citations

Antibody-catalyzed degradation of cocaine

Donald W. Landry;Kang Zhao;Ginger X. Q. Yang;Michael Glickman.
Science (1993)

347 Citations

Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule

Vivek Rao;Nagatoshi Fujiwara;Steven A. Porcelli;Michael S. Glickman.
Journal of Experimental Medicine (2005)

294 Citations

Bacterial DNA repair by non-homologous end joining.

Stewart Shuman;Michael S Glickman.
Nature Reviews Microbiology (2007)

282 Citations

A Gamma Interferon Independent Mechanism of CD4 T Cell Mediated Control of M. tuberculosis Infection in vivo

Alena M. Gallegos;Alena M. Gallegos;Jeroen W. J. van Heijst;Miriam Samstein;Xiaodi Su.
PLOS Pathogens (2011)

239 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Michael S. Glickman

Laurent Kremer

Laurent Kremer

Institut de Recherche en Infectiologie de Montpellier (IRIM)

Publications: 62

Stewart Shuman

Stewart Shuman

Kettering University

Publications: 49

Chang-Guo Zhan

Chang-Guo Zhan

University of Kentucky

Publications: 47

William R. Jacobs

William R. Jacobs

Albert Einstein College of Medicine

Publications: 43

Gurdyal S. Besra

Gurdyal S. Besra

University of Birmingham

Publications: 34

Sabine Ehrt

Sabine Ehrt

Cornell University

Publications: 29

Mamadou Daffé

Mamadou Daffé

Centre national de la recherche scientifique, CNRS

Publications: 26

Joel D. Ernst

Joel D. Ernst

University of California, San Francisco

Publications: 25

Samuel M. Behar

Samuel M. Behar

University of Massachusetts Medical School

Publications: 24

Stefan H. E. Kaufmann

Stefan H. E. Kaufmann

Max Planck Institute for Infection Biology

Publications: 23

Andrea M. Cooper

Andrea M. Cooper

University of Leicester

Publications: 20

Carolyn R. Bertozzi

Carolyn R. Bertozzi

Stanford University

Publications: 20

Aidan J. Doherty

Aidan J. Doherty

University of Sussex

Publications: 20

Seth A. Darst

Seth A. Darst

Rockefeller University

Publications: 19

Carl Nathan

Carl Nathan

Cornell University

Publications: 19

Mihai G. Netea

Mihai G. Netea

Radboud University Nijmegen

Publications: 19

Trending Scientists

Akos Ledeczi

Akos Ledeczi

Vanderbilt University

Bo Li

Bo Li

Fudan University

Leonardo de Moura

Leonardo de Moura

Microsoft (United States)

Gregory A. Keoleian

Gregory A. Keoleian

University of Michigan–Ann Arbor

Raphael Idem

Raphael Idem

University of Regina

Richard J. Nichols

Richard J. Nichols

University of Liverpool

Isabelle M. Côté

Isabelle M. Côté

Simon Fraser University

Takashi Okamoto

Takashi Okamoto

Nagoya City University

Diego Guidolin

Diego Guidolin

University of Padua

Benjamin H. Brinkmann

Benjamin H. Brinkmann

Mayo Clinic

Theresa H.M. Keegan

Theresa H.M. Keegan

University of California, Davis

Klaas R. Westerterp

Klaas R. Westerterp

Maastricht University

Ruth Boaden

Ruth Boaden

University of Manchester

Emmanuel Jehin

Emmanuel Jehin

University of Liège

Katepalli R. Sreenivasan

Katepalli R. Sreenivasan

New York University

Something went wrong. Please try again later.